Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Renal Damage After PCNL and ESWL Using Novel RNA Based Biomarkers

NCT05077007 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT05077007
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05077007 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Renal Damage After PCNL and ESWL Using Novel RNA Based Biomarkers
Lead sponsor
Ain Shams University
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2021
Completion date
November 1, 2022
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, extracorporeal shockwave lithotripsy, percutaneous nephrolithotomy, renal calculi